Abstract: Circadian clocks are regulated at the post-translational level by a variety of processes among which protein phosphorylation plays a prominent, although complex, role. Thus, the phosphorylation of different sites on the clock protein PER by casein kinase I (CKI) can lead to opposite effects on the stability of the protein and on the period of circadian oscillations. Here the authors extend a computational model previously proposed for the mammalian circadian clock by incorporating two distinct phosphorylations of PER by CKI. On the basis of experimental observations the authors consider that phosphorylation at one site (denoted here PER-P1) enhances the rate of degradation of the protein and decreases the period, while phosphorylation at another site (PER-P2) stabilises the protein, enhances the transcription of the Per gene, and increases the period. The model also incorporates an additional phosphorylation of PER by the Glycogen Synthase Kinase 3 (GSK3). The authors show that the extended model incorporating the antagonistic effects of PER phosphorylations by CKI can account for observations pertaining to (i) the decrease in period in the Tau mutant, because of an increase in phosphorylation by CKI leading to PER-P1, and (ii) the familial advanced sleep phase syndrome (FASPS) in which the period is shortened and the phase of the oscillations is advanced when the rate of phosphorylation leading to PER-P2 is decreased. The model further accounts for the increase in period observed in the presence of CKI inhibitors that decrease the rate of phosphorylation leading to both PER-P1 and PER-P2. A similar increase in period results from inhibition of GSK3.
Introduction
Circadian rhythms characterised by a period close to 24 h are observed in all eukaryotic organisms [1] -from fungi, plants and insects to fish and mammals, including humans -and some prokaryotic organisms such as the cyanobacteria [2] . Circadian clocks play a crucial role in the adaptation of these organisms to environmental changes such as the light/ dark (LD) cycle associated with the alternation of day and night. The molecular mechanism underlying the circadian clock is based on negative transcriptional regulatory feedback loops [3] by which a protein or a complex of proteins inhibits directly or indirectly the transcription of its (their) own gene(s). The mechanism of circadian oscillations further involves post-translational modifications among which key roles are played by the phosphorylation of clock proteins such as PER or CRY. Different kinases such as casein kinase I (CKI), glycogen synthase kinase 3 (GSK3) and mitogen-activated protein kinase (MAPK) can act on different clock proteins, often leading to opposite effects on the period and phase of circadian oscillations.
Experimental studies have unravelled the important roles of protein kinases in the generation of circadian rhythms. Mutations that affect phosphorylation often have a marked impact on the period and can even abolish circadian rhythmicity [4] . The role and effect of the kinases in the circadian clock are often very complex and difficult to apprehend. Here are some examples. First, the effect of a kinase could be substrate specific: for example, the CKI tau mutation reduces general kinase activity on most substrates but increases the activity on the PER protein [5] . Second, the DBT L and DBT S mutations in Drosophila lead to a decreasing activity of the kinase and a hypophosphorylation state of the clock protein, but give rise to different phenotypes associated with either long-or short-periods [6] . Third, the CKId T44A mutation shows a phenotype that lengthen circadian period in Drosophila while transgenic mice carrying the same mutation show a shorter period [7] . Fourth, the S662G mutation in hPER2 by a yet unknown kinase may hinder the effect of CKI on the following phosphorylation sites (S665, 668, 671 and 674) [8] . Finally, multiple phosphorylation sites exist on clock proteins [9] that could lead to various functions such as the degradation or stabilisation of the clock protein, a change of subcellular localisation, or a change of transcriptional activity [10] .
Recent findings highlighted a link between phosphorylation of circadian clock proteins and disorders of the sleep-wake cycle. Thus, a sleep disorder known as the familial advanced sleep phase syndrome (FASPS) has been linked to the hypophosphorylation of the human PER2 protein at the site S662 [11] . A similar result was obtained in the CKId T44A human FASPS mutation where the activity of the kinase CKId is reduced in vitro [7] , although some recent experimental results suggest that this mutation may be a gain-of-function [10] . Similarly, the Tau mutation in hamsters, associated with a shortening of the period of circadian oscillations [12] , was first linked to a reduced kinase activity in vitro [13] but was recently shown to be a substrate-specific gain-of-function responsible for enhanced PER phosphorylation leading to its degradation [5] .
Computational modelling represents a powerful tool to investigate the effect of clock protein phosphorylation on circadian rhythmicity. Several models have been proposed for the mammalian circadian clock [14 -16] . The model considered by Leloup and Goldbeter [14] involves a single type of PER phosphorylation that leads to PER degradation. We previously used that model to show that a decrease in the rate of PER phosphorylation by CKI can lead to both a decrease in period in continual darkness dark-dark (DD) and a phase advance in LD [14] , as in FASPS. In contrast, the model proposed by Forger and Peskin [16] leads to a shorter period for higher PER phosphorylation rates. The fact that this result was in apparent contradiction with the experimental observations on the Tau mutant led to a re-examination of the effect of CKI on different substrates [5] . This analysis revealed that the CKI mutation underlying the Tau phenotype represents a gain-of-function [5] . Moreover, the phosphorylation of PER at other sites by CKI appears to be involved in FASPS [8, 9] . Recent experimental studies have indeed shown that although CKI phosphorylates many residues in the PER protein [9] , two distinct sites of phosphorylations in PER could be associated with the FASPS and the Tau mutation, and phosphorylation by CKI at this sites could lead to opposite effects on the period of the circadian clock. Thus, phosphorylation at one site, associated with the Tau phenotype, leads to a decrease in period when the rate of phosphorylation increases, whereas phosphorylation at a second site, associated with FASPS, leads to an increase in period when the phosphorylation rate increases [8] .
The specific role of multiple phosphorylation sites of the PER protein has been examined in simple models for the circadian clock [9] . Here we wish to address the dual role of PER phosphorylation by CKI in an extended version of the more detailed model that we previously proposed for the mammalian circadian clock [14, 15] . The goal of this study is to investigate whether the model incorporating the two distinct sites of PER phosphorylation by CKI, with their opposite effects on the period, can account for the changes in period and phase seen both in the FASPS and in the Tau mutant when the rate of PER phosphorylation is altered.
In the following, we first recall the different roles played by protein phosphorylation in the mechanism of circadian oscillations. We then present an extended version of our molecular model for the mammalian circadian clock, incorporating the two sites of the PER protein phosphorylated by CKI, with their distinct effects on the period, as well as a third site of PER phosphorylated by the kinase GSK3. We next show how the extended model can account for both the FASPS and the Tau phenotype, which result, respectively, from a decrease and from an increase in the rate of PER phosphorylation by CKI at distinct sites on the protein. We then determine the effect of a kinase inhibitor that inhibits the rate of phosphorylation at the two distinct sites of PER simultaneously. The results are discussed in the light of physiological disorders related to dysfunctions of the human circadian clock.
Different roles for phosphorylation in the circadian clock
Several kinases such as casein kinases Id and I1 (CKId and CKI1), GSK3, or MAPK are known to play a key role in the generation of circadian rhythms [4] . Among them, CKI plays an essential role by phosphorylating the PER protein and marking it for proteasomal degradation [5, 17] . Recent experimental observations pointed to a second and opposite role for the phosphorylation of PER2 (one of the three forms PER1, PER2 and PER3 of mammalian PER) by CKI [8, 9] . This phosphorylation appears to stabilise the PER2 protein either through increased nuclear retention, and hence decreased protein degradation [9] , or through increased Per2 transcription [8] . The PER protein is also phosphorylated on another site by the kinase GSK3 [18] . The kinases CKI and GSK3 appear to have distinct effects on the different forms of the PER protein. Thus, CKI controls the nuclear entry of PER1 and PER3 but not PER2 [19 -21] , whereas GSK3 promotes the nuclear entry of PER2 but not PER1 or PER3 [18] . Besides the PER proteins, other clock protein may serve as substrates for the CKI and GSK3 kinases. Thus, CKI also phosphorylates the CRY proteins when they are complexed with PER; it also phosphorylates BMAL1, leading to a change of transcriptional activity of the CLOCK -BMAL1 complex [22] . Moreover, besides promoting the nuclear entry of PER2 [18] , GSK3 increases the proteasomal degradation of CRY2 [23] and also leads to the stabilisation of REVERBa [24] .
Extended model for the mammalian circadian clock
In our original model [14] we took into account a single phosphorylation of PER and CRY by CKI. To test the differential roles of the kinases CKI and GSK3 involved in the circadian clock, we need to extend the computational model to incorporate explicitly three different phosphorylation sites of PER (see Supplementary Material for a full description and scheme of the extended model). Recent experimental data showed that the two isoforms CKId and CKI1 could play different roles in regulating the circadian clock [10, 25, 26] , and that numerous phosphorylation sites exist on PER in mammals [9] . In our extended model, we will not differentiate the two isoforms of CKI or take into account all the phosphorylation sites. We will rather focus on three phosphorylation sites with three different functions. A first site phosphorylated by CKI (leading to the phosphorylated form PER-P1) brings about the degradation of the protein [5] . A second site phosphorylated by CKI (leading to the phosphorylated form PER-P2) leads to the stabilisation of PER [8, 9] . The effects of these two phosphorylation sites are schematised in Fig. 1 . A third site phosphorylated this time by GSK3 (leading to the phosphorylated form PER-P3) promotes the nuclear translocation of PER [18] .
The model incorporating these three phosphorylation sites of PER is schematised in Fig. A1 (see Supplementary Material for further details). This extended model allows us to test (i) the origin of the phenotype of the CKI Tau mutant [5] in which hyperphosphorylation of PER is associated with a higher rate of PER degradation (this situation will be simulated in the model by increasing the rate of phosphorylation leading to PER-P1); (ii) the origin of the FASPS mutation [11] in which hypophosphorylation of PER is associated with increased nuclear retention and decreased degradation in vitro [9] and with lower Per mRNA levels in vivo [8] (this situation will be simulated in the model by decreasing the rate of phosphorylation leading to PER-P2); (iii) the effect of a non-specific CKI inhibitor [27] (this situation will be simulated in the model by decreasing simultaneously the rates of phosphorylation leading to PER-P1 and PER-P2); (iv) the change in period associated with inhibition of GSK3 [18] .
Modelling the FASPS and the Tau mutant
Because two distinct sites of PER phosphorylated by CKI are considered in the extended model, we can directly test the effect of a change in either one or both of these phosphorylation sites. If we increase the rate of phosphorylation (V phos1 ) by CKI leading to PER-P1 without changing the rate of phosphorylation (V phos2 ) leading to PER-P2 (which is held at its basal value; see Table 1 in the Supplementary Material, where basal parameter values are listed), the period in DD is shortened as compared with the wild type (Fig. 2a) . The phase of the oscillations upon entrainment in LD is then advanced by a few hours as compared with the wild type (Fig. 2c) . This behaviour fits with the shortening of the period in DD and the advance of the phase in LD in the Tau mutant, in which the rate of PER phosphorylation is enhanced through a gain-offunction mutation [5] . Mechanistically, parameter V phos1 measures the maximum phosphorylation rate of the first PER site by CKI, leading to PER-P1 and marking PER for degradation [5, 17] .
Turning to the case of FASPS, we observe that if we decrease the rate of phosphorylation (V phos2 ) by CKI leading to PER-P2 while keeping the rate of phosphorylation (V phos1 ) leading to PER-P1 at its basal value, the period in DD is shortened as compared with the normal case type (Fig. 2b) . Moreover, the phase of the oscillations in LD is then advanced by several hours Fig. 1 Antagonistic effects of PER phosphorylations by the kinase CKI on PER stability and on the period of circadian oscillations a Phosphorylation leading to PER-P1 enhances PER degradation. The Tau mutant in hamster [7] shows a gain of function of PER phosphorylation by CKI leading to shorter period [8] b Phosphorylation leading to PER-P2 indirectly stabilises the protein by increasing the levels of Per mRNA, through weaker inhibition by PER of the complex CLOCK-BMAL1 that induces the expression of the Per gene [13] . The FASPS mutation in humans is associated with hypophosphorylation of PER leading to shorter period [5] Table 1 in Supplementary Material, except for the Tau mutant where V phos1 ¼ 1.2 nM/h (instead of 1 nM/h for the wild type) and for the FASPS where V phos2 ¼ 0.9 nM/h (instead of 1.12 nM/h for the 'normal' situation). In panels c and d, to simulate the effect of light, which induces Per transcription, the maximum value of the rate of Per expression, v sP , varies in a square-wave manner such that it remains at a constant low value of 4.0 nM/h during the 12 h long dark phase (grey rectangle), and is raised up to the high value of 4.4 nM/h during the 12 h long light phase (white rectangle) (Fig. 2d) . The results in both panels b and d of Fig. 2 match the observations on FASPS, which is associated with a decrease in PER phosphorylation [11] .
A more detailed picture of the effect of a change in either V phos1 or V phos2 is shown in panels a -d of Fig. 3 . If we only increase V phos1 , the period in DD drops before levelling to a plateau ( Fig. 3a) . At the same time the phase is advanced in LD (Fig. 3b) . The latter change is very steep as an advance of as much as 5 h occurs over a reduced range of V phos1 values. Outside this range the effect of a change in V phos1 results in much smaller phase advances.
The effects of an increase in V phos2 are opposite. The period of circadian oscillations lengthens as the rate of phosphorylation by CKI leading to PER-P2 rises (Fig. 3c) . At the same time the phase of the oscillations upon entrainment in LD is delayed compared to the normal case (Fig. 3d ) . The change in phase is again very steep as the oscillations are delayed by about 5 h as a result of a tiny increase in V phos2 . On either side of this range the phase changes in a much smoother manner (Fig. 3d ) . As already noted for Fig. 2 , these results hold with those obtained for the FASPS mutation, for which the period is shorter [28] and the phase of the oscillations is advanced by several hours [11] . When we decrease the rate of phosphorylation V phos2 in the extended model for the circadian clock (thus mimicking the FASPS mutant) we indeed decrease the period (Fig. 3c) , and advance the phase of the oscillations in LD (Fig. 3d ) .
Modelling the effect of kinase inhibitors
What happens if the rates of phosphorylation by CKI leading to both PER-P1 and PER-P2 change simultaneously, for example, as a result of overexpression or inhibition of the kinase? To address this question we multiply both V phos1 and V phos2 by a factor m, the basal value of which is equal Fig. 3 Distinct PER phosphorylations by CKI have opposite effects on the free running period in DD (left panels) and on the phase of circadian oscillations in LD (right panels) a and b Phosphorylation leading to PER-P1: the period first decreases rapidly then increases slowly when the rate of phosphorylation V phos1 rises a. At the same time the phase of Per mRNA advances from the end towards the beginning of the light phase b c and d Phosphorylation leading to PER-P2; the period continuously increases as V phos2 rises (c), and the phase of Per mRNA is delayed from the beginning towards the end of the light phase d e and f Effect of changing simultaneously the rates of phosphorylation to PER-P1 and PER-P2. When the rates V phos1 and V phos2 are multiplied by the factor m, the period in DD first decreases rapidly then increases slowly as m increases e. At the same time, the phase of Per mRNA is first advanced from the end towards the beginning of the light phase, and then delayed again towards the end of the light phase f Curves in a -f have been obtained by numerical integration of (1) Table 1 in Supplementary Material. The black dots on each curve correspond to unperturbed (i.e. wild type or 'normal') circadian oscillations (see Fig. 2 ) for which parameters keep their basal values listed in Table 1 in Supplementary Material to 1. In DD, as m increases from zero -oscillations can occur for this value in the model, with a very long period, in the absence of phosphorylation -the period first decreases rapidly before undergoing a slight increase (Fig. 3e) . In conditions of entrainment by LD cycles, we observe a sequential combination of the effects of changing either V phos1 or V phos2 alone. Thus, as m increases, the phase slightly advances, then undergoes a sharp advance, reaches a plateau, displays a steep delay, before it reaches a new constant value (Fig. 3f ) .
The results of panels e and f in Fig. 3 indicate that the addition of an inhibitor of the kinase CKI can have markedly different effects, depending on the basal value of parameter m. Thus, starting from a very high value corresponding to the right part of the curves in Figs. 3e and f, a progressive decrease in m -corresponding to the progressive inhibition of the two phosphorylation sites performed by CKI -will result in a slight decrease, and later in a steep increase in period while at the same time the phase will first advance, then will reach a plateau, before undergoing a steep delay.
Inhibitors of CKI were tested experimentally and all showed longer periods for the oscillations [17, 27] . Fig. 3e suggests that if we start in the middle or left part of the curve, decreasing the rate of phosphorylation V phos1 and V phos2 together (thus mimicking an inhibitor or a functionally inactive mutant of CKI) leads to lengthening of the period. This longer period is also associated with delays (see Fig. 3f ) when the system is entrained by LD cycles [27] . Likewise, the specific inhibition of GSK3 (obtained by reducing parameter V phos3 in the model) leads to an increase in period, up to 65 h. The period may subsequently decrease to about 50 h as the value of V phos3 approaches zero.
Discussion
The phosphorylation of clock proteins plays important, although complex, roles in the molecular mechanism of circadian rhythms. Thus, experimental studies, often helped by theoretical predictions, have recently shown [5, 8, 9 ] that the kinase CKI phosphorylates PER in two distinct residues with antagonistic effects on the period and phase of circadian oscillations (Fig. 1) . Disorders of the sleep -wake cycle such as the FASPS are associated with mutations affecting PER phosphorylation [11] . If we wish to use computational models to address the dynamical bases of such physiological disorders, we need to incorporate the complexity of PER phosphorylations by CKI into models for the mammalian circadian clock. We therefore extended a model previously proposed for the mammalian circadian clock by considering two distinct PER sites phosphorylated by CKI. A first site phosphorylated by CKI leading to PER-P1 elicits degradation of the protein, whereas a second site of phosphorylation leading to PER-P2 stabilises PER (Fig. 1) . Also incorporated into the extended model (see Fig. A1 in the Supplementary Material) is the phosphorylation by the kinase GSK3 of a third residue, leading to the form PER-P3.
Using the extended model for the mammalian circadian clock we determined the effect of a change in the rate of phosphorylation of PER by CKI leading to either PER-P1 (V phos1 ) or PER-P2 (V phos2 ). We showed that an increase in the phosphorylation rate V phos1 causes a decrease in period and a phase advance, as observed in the Tau mutant, in which the mutation corresponds to a gain-of-function of CKI. A change in the phosphorylation rate V phos2 brings about opposite effects. Here, indeed, it is a decrease in V phos2 that produces period shortening and an advance of the phase of the oscillations (Figs. 2 and 3) , as observed in the FASPS which is associated with hypophosphorylation of PER [11] . Simultaneously changing both V phos1 and V phos2 (e.g. by using an inhibitor of CKI) combines the two effects and produces a highly complex dependence of the phase as a function of the two rates of PER phosphorylation.
For the sake of simplicity, we only took into account in our model one form of CKI and did not differentiate between the delta and the epsilon isoforms because of their possible redundant functions [29] . Experimental data further suggest that the clock can compensate for the loss of CKI1 [29] or CKId [10] , even though the latter enzyme appears to influence more significantly the period of circadian oscillations [10, 25, 26] . Removal of one copy of CKId in mice or addition of one to two genomic copies of a CKId transgene does not change the period [8] . This latter result could be explained by the balance between the two phosphorylation sites (linked with PER-P1 and PER-P2 in the model) leading to opposing effects. Fig. 3e shows a large region where increasing or decreasing the level of the kinase has only a minor impact on the period. Finally, recent experimental data suggest that CKId and CKI1 may phosphorylate overlapping but distinct groups of residues on PER protein [10] .
Several experimental studies showed that a reduction of the kinase activity in DOUBLETIME (DBT) in Drosophila [30] or in CKI in mammals [25, 27] generally lead to an increase in period. This contrasts with previous results [7, 11] showing that a hypophosphorylation of PER2 is responsible for the short period observed in FASPS patients. Although the present results provide an explanation for FASPS and Tau in terms of a decrease and an increase in CKI activity, respectively, it remains possible that the FASPS could be associated -as in the case of the Tau mutant [5] -with a gain-of-function leading to an hyperphosphorylation of the PER proteins [10] .
That the period is very sensitive to changes in components of the negative loop was already made clear by simulations of several core models for circadian oscillations. Varying the rate of degradation (with or without prior phosphorylation) of a clock protein in such minimal models can lead to radically different period profiles [31] .
Two successive phosphorylations of PER were previously considered in a simpler model for circadian oscillations in Drosophila [32, 33] . However, the two phosphorylations played similar roles in that model. Two phosphorylations with distinct roles were considered in a model of the Goodwin type for circadian oscillations, with regard to disorders associated with mutations affecting the circadian clock [9] . Here, we incorporated the distinct roles played by the two sites of PER phosphorylated by CKI, with opposite effects on the period and phase, in a detailed model for the mammalian circadian clock. We showed that this extension of the model allows us to account for syndromes or phenotypes associated with mutations affecting one or the other phosphorylation site by CKI.
Besides CKId and CKI1, GSK3 is another kinase that plays a major role in the regulation of the circadian clock. GSK3 promotes the nuclear entry of PER2 [18] , increases the proteasomal degradation of CRY2 [23] , leads to the stabilisation of REV-ERBa [24] , mediates CLOCK degradation and transcriptional activity [34] , and regulates BMAL1 stability [35] . We will examine elsewhere in further detail the effect of changing the multiple targets of GSK3 in the circadian clock. Here, we explicitly took into consideration in our model the PER phosphorylation by GSK3 (the rate of this phosphorylation is measured by parameter V phos3 ) that leads to its nuclear entry. This issue is of interest with respect to the treatment of mood disorders, given that lithium -which is commonly used in the treatment of bipolar disorders -is an inhibitor of several kinases and in particular of GSK3 [36, 37] . Lithium may therefore achieve its clinical effect by affecting the period and phase of the circadian clock. In support of this view is the finding that lithium lengthens the period of circadian oscillations [24, 37] . Accordingly, the period of circadian oscillations increases in the extended model for the mammalian circadian clock when the value of the rate of phosphorylation of PER by GSK3 decreases, which fits with the slowing down of the clock in the presence of GSK3 inhibitors such as lithium. 
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A1. Extended model for the mammalian circadian clock
The extended model is schematized in Figure A1 . It incorporates the following molecular processes (in parentheses we give the symbols denoting the concentrations of the different variables that appear in the equations listed below): 2) Translation of these mRNAs into the cytosolic, unphosphorylated proteins PER, CRY, BMAL1, and REV-ERBα (denoted by cP, cC, cB, cR). For all cytosolic proteins or complexes considered, the first letter of the name of the variable is "c"; in the case of nuclear forms, the first letter is "n".
3) Formation of the PER-CRY complex in the cytosol (its concentration is denoted cPC for the unphosphorylated form of the complex or cPCP1 for the mono-phosphorylated form). 
The extension involves dual phosphorylation of PER by casein kinase (CKI) leading to PER-P1 or PER-P2, and the additional phosphorylation of PER by the kinase GSK3, leading to PER-P3 (see below for a detailed description of the model).
and simulated here by lowering the rate of PER degradation, or (ii) by increasing the rate of transcription of Per mRNA (as hypothesized by Xu et al. [4] ) and simulated here by decreasing PER affinity for the CLOCK-BMAL1
complex. Both assumptions regarding the effect of phosphorylation of PER in P2 will be retained. Finally, a third phosphorylation of the PER protein by GSK3 (in a site named P3) enables the PER protein to enter the nucleus [5] .
Concentrations of the phosphorylated forms of PER are denoted by adding "P1", "P2" or "P3" to the previous form of the PER protein or PER-CRY complex. For example, if the cytosolic unphosphorylated form of the PER-CRY complex (cPC) is phosphorylated by CKI at P1, the concentration of the resulting phosphorylated form of PER will be denoted cPCP1. If it is phosphorylated by GSK3, then it will be denoted cPCP3. The different free forms of the PER proteins are denoted cP, cPP1, and those of the PER-CRY complexes are denoted cPC, cPCP1, cPCP3, cPCP1P3, nPCP3, nPCP1P3, nPCP2P3, and nPCP1P2P3.
5) Reversible phosphorylation of the BMAL1 protein (nB) is also considered (the concentration of the phosphorylated form is denoted nBP).
6) Reversible entry of the cytosolic PER-CRY complexes into the nucleus after PER phosphorylation by GSK3 (the concentrations of the cytosolic and nuclear forms of the complexes are denoted by cPCP3 and cPCP1P3, and nPCP3, nPCP1P3, respectively).
7) Reversible entry of the cytosolic BMAL1 and REV-ERBα proteins into the nucleus (the concentrations of the cytosolic and nuclear forms of BMAL1 and REV-ERBα are denoted by cB, nB and cR, nR, respectively).
8)
In agreement with experimental observations, the expression of Clock is considered to be constitutive and to give rise to a high, constant level of cytosolic and nuclear CLOCK protein [6] . We will not distinguish between the phosphorylated and unphosphorylated forms of CLOCK and will treat its constant level as a parameter. We assume that once in the nucleus, BMAL1 immediately forms a complex with CLOCK.
9) In the nucleus, the CLOCK-BMAL1 complex (nBP) activates the transcription of the Per, Cry and Rev-Erbα genes. By binding to the CLOCK-BMAL1 complex, the PER-CRY complex prevents this activation by forming an inactive complex, which is directly degraded. Such a regulation amounts to indirect repression of the Per and Cry genes by their protein products.
10) The negative autoregulation exerted by BMAL1 on the expression of its gene was shown to be of indirect nature:
BMAL1 promotes the expression of the Rev-Erbα gene and the REV-ERBα protein represses the expression of Bmal1 [7] .
11) Experimental evidence indicates that PER2, and to a lesser degree CRY1 and CRY2, behave as activators of Bmal1 transcription [6, 8] . We assume that the positive feedback occurs indirectly and that CLOCK-BMAL1
represses -through the repressor REV-ERBα -the transcription of the gene Bmal1; the activating effect of PER2, CRY1 and CRY2 would be due to the removal of repression upon formation of the complex between PER-CRY and CLOCK-BMAL1.
12) The effect of light is to enhance transcription of the Per gene and is incorporated into the model through modulation of the maximum rate of Per expression, denoted by v sP . The model thereby allows us to study the dynamics of the circadian clock mechanism in conditions corresponding to continuous darkness or entrainment by light-dark cycles.
A family of closely related models can be built based on the above assumptions. Here we focus on one particular implementation of such models. Alternative versions of the circadian clock model based on slightly different implementations of the above hypotheses yield largely similar results. Thus, BMAL1 may form a complex with CLOCK before entering the nucleus, whereas complexes between CRY and PER or between CLOCK and BMAL1 may also form when the various proteins are phosphorylated. Moreover, we treated the different phosphorylations of the PER proteins in a sequential order (e.g., PER-P1 formation precedes the formation of PER-P1P2) but a different order or parallel phosphorylations likely lead to similar results.
The choice of the value of the parameters was obtained by a system of trials and errors. We created multiple sets of parameters that we tested in comparison with experimental data [3] [4] [5] [6] [7] [8] and kept the parameter set (shown in Table 1) that qualitatively fits with these data. The aim of the model was to incorporate and study the effect of phosphorylations on different clock proteins. The model was built up in order to account for the differential effects of the phosphorylation such as degradation or stabilization of the proteins or change in subcellar localization (parameters V phos1 , V phos2 , and V phos3 , respectively). At this stage, the model is mainly of qualitative (rather than quantitative) nature and fits well with experimental data for the different mutants such as FASPS or Tau. We plan in the future to use methods of optimization [9, 10] in order to further analyze the dynamical behavior of the model and give rise to more quantitative predictions. A sensitivity analysis [11] [12] [13] will also be performed and will help us to determine the robustness of the model to perturbations.
The effect of knockout mutations on phenotype could be drastically different when assessed at the cellular level or at the tissue or organismal levels. Intracellular coupling can give rise to robustness to the cellular network but can mask cell-autonomous circadian phenotypes [10] . Because cell-autonomous and behavioral phenotypes may differ [14] , cellular models could not be as accurate as expected. Nevertheless, several theoretical models have confirmed that such a "reduction" (i.e. considering one cell instead of a tissue or the whole organism) remains highly useful [15, 16] . Moreover, experimental data showed that a mutation at the level of one gene is at the origin of the FASPS and showed consequences at the behavioral level [17] . In the present approach, we used experimental data [3] [4] [5] [6] [7] [8] 
A2. Kinetic equations
The time evolution of the model of Figure A1 is governed by the system of 20 kinetic equations (1)- (20) . For the sake of clarity, we have grouped these equations for the various mRNAs, the phosphorylated and nonphosphorylated PER proteins or PER-CRY complexes, and the different forms of the CRY, BMAL1 and REV-ERbα proteins :
Equations for mRNAS :
Equations for PER proteins and PER-CRY complexes : (14) Equations for CRY, BMAL1 and REV-ERBα proteins:
The definition of the various parameters is given in Table 1 in section A3 below. In Eqs. (1)- (20), concentrations are defined with respect to the total cell volume. kdn (h -1 ) Nonspecific degradation rate constant for mRNA and proteins species 0.01
A3. Definition and basal values of the parameters
